| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 84 | 2024 | 724 | 11.750 |
Why?
|
| Stress Disorders, Post-Traumatic | 29 | 2022 | 365 | 5.340 |
Why?
|
| United States Department of Veterans Affairs | 48 | 2023 | 514 | 3.500 |
Why?
|
| Military Personnel | 11 | 2023 | 97 | 3.470 |
Why?
|
| Veterans Health | 17 | 2023 | 156 | 3.290 |
Why?
|
| Mental Disorders | 26 | 2022 | 765 | 3.030 |
Why?
|
| Schizophrenia | 14 | 2015 | 256 | 2.370 |
Why?
|
| United States | 101 | 2024 | 7515 | 2.100 |
Why?
|
| Patient Readmission | 16 | 2021 | 420 | 1.920 |
Why?
|
| Iraq War, 2003-2011 | 10 | 2022 | 57 | 1.650 |
Why?
|
| Comorbidity | 29 | 2020 | 1090 | 1.630 |
Why?
|
| Female | 139 | 2024 | 30893 | 1.610 |
Why?
|
| Middle Aged | 106 | 2024 | 16256 | 1.590 |
Why?
|
| Afghan Campaign 2001- | 10 | 2016 | 54 | 1.570 |
Why?
|
| Male | 133 | 2024 | 27556 | 1.530 |
Why?
|
| Resilience, Psychological | 3 | 2022 | 55 | 1.500 |
Why?
|
| Aged | 93 | 2021 | 13340 | 1.440 |
Why?
|
| Humans | 173 | 2024 | 59454 | 1.410 |
Why?
|
| Surgical Procedures, Operative | 8 | 2019 | 139 | 1.370 |
Why?
|
| Aged, 80 and over | 53 | 2020 | 5098 | 1.360 |
Why?
|
| Hospitals, Veterans | 19 | 2021 | 159 | 1.360 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2020 | 448 | 1.290 |
Why?
|
| Adult | 80 | 2024 | 15767 | 1.250 |
Why?
|
| Postoperative Complications | 14 | 2020 | 1133 | 1.230 |
Why?
|
| Analgesics, Opioid | 13 | 2020 | 495 | 1.190 |
Why?
|
| Primary Health Care | 8 | 2021 | 649 | 1.180 |
Why?
|
| Retrospective Studies | 55 | 2024 | 6007 | 1.160 |
Why?
|
| Mental Health Services | 9 | 2020 | 299 | 1.130 |
Why?
|
| Opioid-Related Disorders | 8 | 2022 | 465 | 1.040 |
Why?
|
| Disinfection | 6 | 2020 | 20 | 1.020 |
Why?
|
| Vascular System Injuries | 2 | 2022 | 19 | 0.960 |
Why?
|
| Young Adult | 29 | 2024 | 4320 | 0.920 |
Why?
|
| Diabetes Mellitus | 3 | 2024 | 537 | 0.910 |
Why?
|
| Suicide | 6 | 2015 | 123 | 0.890 |
Why?
|
| Risk Factors | 28 | 2020 | 5010 | 0.880 |
Why?
|
| Cardiovascular Diseases | 6 | 2018 | 819 | 0.870 |
Why?
|
| Chronic Pain | 9 | 2022 | 142 | 0.870 |
Why?
|
| Xenon | 4 | 2018 | 7 | 0.860 |
Why?
|
| Depression | 15 | 2020 | 859 | 0.860 |
Why?
|
| Bipolar Disorder | 7 | 2012 | 254 | 0.840 |
Why?
|
| Depressive Disorder, Major | 3 | 2022 | 258 | 0.840 |
Why?
|
| Mortality | 3 | 2016 | 160 | 0.830 |
Why?
|
| Obesity | 7 | 2018 | 1185 | 0.820 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2018 | 66 | 0.800 |
Why?
|
| Multivariate Analysis | 14 | 2019 | 925 | 0.790 |
Why?
|
| Psychotropic Drugs | 3 | 2018 | 83 | 0.790 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2022 | 11 | 0.780 |
Why?
|
| Patient Discharge | 6 | 2019 | 479 | 0.750 |
Why?
|
| Mental Health | 7 | 2021 | 350 | 0.740 |
Why?
|
| Pneumonia | 10 | 2017 | 270 | 0.730 |
Why?
|
| Health Literacy | 2 | 2020 | 77 | 0.720 |
Why?
|
| Hypertension | 3 | 2024 | 600 | 0.710 |
Why?
|
| Pain | 8 | 2018 | 405 | 0.700 |
Why?
|
| Hip Fractures | 2 | 2018 | 79 | 0.690 |
Why?
|
| Epilepsy | 6 | 2011 | 111 | 0.690 |
Why?
|
| Antidepressive Agents | 8 | 2022 | 229 | 0.680 |
Why?
|
| Cohort Studies | 29 | 2024 | 2443 | 0.680 |
Why?
|
| Patients' Rooms | 3 | 2020 | 7 | 0.670 |
Why?
|
| Cesarean Section | 1 | 2021 | 96 | 0.670 |
Why?
|
| Health Services | 5 | 2015 | 85 | 0.640 |
Why?
|
| Antipsychotic Agents | 9 | 2016 | 312 | 0.620 |
Why?
|
| Health Services Accessibility | 8 | 2021 | 541 | 0.610 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2019 | 212 | 0.600 |
Why?
|
| Sex Characteristics | 3 | 2020 | 196 | 0.600 |
Why?
|
| Hypertriglyceridemia | 1 | 2018 | 10 | 0.590 |
Why?
|
| Rape | 1 | 2017 | 14 | 0.580 |
Why?
|
| Hospitalization | 10 | 2016 | 1283 | 0.580 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2016 | 105 | 0.580 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2018 | 142 | 0.570 |
Why?
|
| Multiple Chronic Conditions | 1 | 2017 | 34 | 0.560 |
Why?
|
| Pancreatitis | 1 | 2018 | 101 | 0.560 |
Why?
|
| General Surgery | 2 | 2021 | 187 | 0.550 |
Why?
|
| Time Factors | 21 | 2020 | 3578 | 0.550 |
Why?
|
| Vaccination | 2 | 2016 | 337 | 0.550 |
Why?
|
| Anticonvulsants | 4 | 2012 | 95 | 0.550 |
Why?
|
| Psychotherapy | 4 | 2016 | 89 | 0.540 |
Why?
|
| Healthcare Disparities | 3 | 2015 | 331 | 0.530 |
Why?
|
| Triglycerides | 1 | 2018 | 242 | 0.530 |
Why?
|
| Sex Factors | 6 | 2020 | 961 | 0.520 |
Why?
|
| Adolescent | 24 | 2024 | 5917 | 0.520 |
Why?
|
| Medication Adherence | 6 | 2018 | 254 | 0.510 |
Why?
|
| Pregnancy | 8 | 2024 | 2354 | 0.500 |
Why?
|
| Quality Improvement | 3 | 2017 | 425 | 0.500 |
Why?
|
| Adaptation, Psychological | 4 | 2022 | 264 | 0.490 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2018 | 115 | 0.490 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 133 | 0.490 |
Why?
|
| Quality of Life | 7 | 2020 | 1118 | 0.490 |
Why?
|
| Prospective Studies | 10 | 2021 | 3096 | 0.480 |
Why?
|
| Fathers | 1 | 2015 | 26 | 0.480 |
Why?
|
| Socioeconomic Factors | 8 | 2020 | 782 | 0.480 |
Why?
|
| Organ Transplantation | 1 | 2015 | 51 | 0.480 |
Why?
|
| Wounds and Injuries | 3 | 2017 | 237 | 0.480 |
Why?
|
| Vietnam Conflict | 1 | 2014 | 23 | 0.480 |
Why?
|
| Psychotic Disorders | 4 | 2015 | 151 | 0.470 |
Why?
|
| Logistic Models | 12 | 2017 | 1252 | 0.460 |
Why?
|
| Patient Compliance | 5 | 2010 | 371 | 0.460 |
Why?
|
| Medicaid | 1 | 2018 | 341 | 0.460 |
Why?
|
| Guideline Adherence | 2 | 2014 | 296 | 0.450 |
Why?
|
| Proportional Hazards Models | 7 | 2016 | 673 | 0.440 |
Why?
|
| Suicide, Attempted | 5 | 2018 | 103 | 0.430 |
Why?
|
| Quality Indicators, Health Care | 4 | 2018 | 330 | 0.430 |
Why?
|
| Age Factors | 10 | 2020 | 1516 | 0.420 |
Why?
|
| Body Mass Index | 7 | 2018 | 885 | 0.420 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 245 | 0.410 |
Why?
|
| Combat Disorders | 1 | 2012 | 10 | 0.400 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 421 | 0.400 |
Why?
|
| Ultraviolet Rays | 4 | 2018 | 125 | 0.400 |
Why?
|
| Longitudinal Studies | 8 | 2024 | 1225 | 0.390 |
Why?
|
| Environmental Microbiology | 3 | 2018 | 13 | 0.390 |
Why?
|
| Mothers | 1 | 2015 | 261 | 0.390 |
Why?
|
| Cost of Illness | 2 | 2010 | 155 | 0.390 |
Why?
|
| Prevalence | 11 | 2024 | 1284 | 0.390 |
Why?
|
| Depressive Disorder | 3 | 2020 | 293 | 0.370 |
Why?
|
| Heart Failure | 5 | 2018 | 867 | 0.370 |
Why?
|
| Antimanic Agents | 2 | 2009 | 29 | 0.370 |
Why?
|
| Maternal Health Services | 2 | 2023 | 64 | 0.370 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 2327 | 0.370 |
Why?
|
| Geriatric Assessment | 2 | 2017 | 161 | 0.370 |
Why?
|
| Military Psychiatry | 1 | 2010 | 2 | 0.360 |
Why?
|
| Odds Ratio | 13 | 2015 | 773 | 0.360 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 249 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 740 | 0.340 |
Why?
|
| Prediabetic State | 1 | 2010 | 52 | 0.340 |
Why?
|
| September 11 Terrorist Attacks | 3 | 2020 | 21 | 0.340 |
Why?
|
| Prescription Drugs | 2 | 2020 | 50 | 0.340 |
Why?
|
| Treatment Outcome | 12 | 2020 | 5174 | 0.330 |
Why?
|
| Alcohol Drinking | 4 | 2008 | 299 | 0.330 |
Why?
|
| Attitude to Health | 7 | 2011 | 275 | 0.330 |
Why?
|
| Drug Prescriptions | 3 | 2014 | 189 | 0.320 |
Why?
|
| Crime Victims | 1 | 2009 | 32 | 0.310 |
Why?
|
| Metabolic Syndrome | 2 | 2024 | 148 | 0.310 |
Why?
|
| Prognosis | 7 | 2020 | 1572 | 0.310 |
Why?
|
| Cyclothymic Disorder | 1 | 2008 | 1 | 0.300 |
Why?
|
| Self Care | 1 | 2010 | 211 | 0.300 |
Why?
|
| Blood Glucose | 1 | 2010 | 471 | 0.300 |
Why?
|
| Intraoperative Complications | 1 | 2008 | 81 | 0.290 |
Why?
|
| Pain, Postoperative | 2 | 2019 | 129 | 0.290 |
Why?
|
| Survival Analysis | 6 | 2016 | 553 | 0.290 |
Why?
|
| Mass Screening | 3 | 2019 | 647 | 0.290 |
Why?
|
| Risk Assessment | 8 | 2020 | 1913 | 0.290 |
Why?
|
| Alcoholism | 2 | 2021 | 307 | 0.290 |
Why?
|
| Telemedicine | 2 | 2010 | 336 | 0.280 |
Why?
|
| Confidence Intervals | 6 | 2011 | 255 | 0.280 |
Why?
|
| Prisoners | 1 | 2009 | 166 | 0.280 |
Why?
|
| Bacteria, Aerobic | 2 | 2018 | 4 | 0.280 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2015 | 142 | 0.280 |
Why?
|
| Preoperative Period | 4 | 2019 | 58 | 0.270 |
Why?
|
| Surveys and Questionnaires | 11 | 2022 | 2594 | 0.260 |
Why?
|
| Prostatic Neoplasms | 2 | 2008 | 319 | 0.260 |
Why?
|
| Morals | 3 | 2020 | 22 | 0.260 |
Why?
|
| Dalteparin | 1 | 2005 | 3 | 0.260 |
Why?
|
| Suicidal Ideation | 5 | 2022 | 113 | 0.260 |
Why?
|
| International Classification of Diseases | 3 | 2024 | 143 | 0.250 |
Why?
|
| Military Medicine | 1 | 2005 | 11 | 0.250 |
Why?
|
| Brachytherapy | 1 | 2005 | 40 | 0.250 |
Why?
|
| Pain Measurement | 4 | 2020 | 330 | 0.250 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2020 | 715 | 0.250 |
Why?
|
| Databases, Factual | 8 | 2020 | 839 | 0.250 |
Why?
|
| Thromboembolism | 1 | 2005 | 70 | 0.250 |
Why?
|
| Lung Diseases | 1 | 2007 | 164 | 0.250 |
Why?
|
| Survival Rate | 5 | 2020 | 790 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 243 | 0.240 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2016 | 80 | 0.240 |
Why?
|
| Gender Dysphoria | 1 | 2024 | 2 | 0.240 |
Why?
|
| Community-Acquired Infections | 4 | 2017 | 87 | 0.240 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 2473 | 0.240 |
Why?
|
| Heart Valve Prosthesis | 1 | 2005 | 90 | 0.230 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 172 | 0.230 |
Why?
|
| Patients | 2 | 2021 | 103 | 0.230 |
Why?
|
| Social Support | 5 | 2021 | 360 | 0.230 |
Why?
|
| Pirenzepine | 1 | 2003 | 5 | 0.220 |
Why?
|
| Anxiety Disorders | 3 | 2021 | 188 | 0.220 |
Why?
|
| Testosterone | 1 | 2024 | 111 | 0.220 |
Why?
|
| Health Status | 5 | 2019 | 449 | 0.220 |
Why?
|
| Transgender Persons | 1 | 2024 | 62 | 0.220 |
Why?
|
| Alcohol-Related Disorders | 1 | 2003 | 36 | 0.210 |
Why?
|
| Child | 6 | 2024 | 4307 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2020 | 66 | 0.210 |
Why?
|
| Quetiapine Fumarate | 2 | 2018 | 13 | 0.210 |
Why?
|
| Aspirin | 2 | 2015 | 170 | 0.200 |
Why?
|
| Infertility | 1 | 2023 | 33 | 0.200 |
Why?
|
| Demography | 6 | 2020 | 178 | 0.200 |
Why?
|
| Medical Audit | 2 | 2014 | 60 | 0.200 |
Why?
|
| Patient Satisfaction | 5 | 2010 | 411 | 0.200 |
Why?
|
| Injury Severity Score | 1 | 2022 | 99 | 0.190 |
Why?
|
| Premature Birth | 1 | 2023 | 108 | 0.190 |
Why?
|
| Norepinephrine | 1 | 2022 | 99 | 0.190 |
Why?
|
| Incidence | 8 | 2018 | 1237 | 0.190 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2020 | 126 | 0.190 |
Why?
|
| Anticoagulants | 1 | 2005 | 485 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2022 | 68 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2024 | 521 | 0.180 |
Why?
|
| Health Services Research | 3 | 2012 | 270 | 0.180 |
Why?
|
| Depression, Postpartum | 2 | 2020 | 162 | 0.180 |
Why?
|
| Combined Modality Therapy | 3 | 2012 | 354 | 0.180 |
Why?
|
| War Exposure | 1 | 2020 | 3 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 796 | 0.170 |
Why?
|
| Drug Utilization | 2 | 2019 | 223 | 0.170 |
Why?
|
| Extremities | 1 | 2020 | 50 | 0.170 |
Why?
|
| Autism Spectrum Disorder | 1 | 2024 | 179 | 0.170 |
Why?
|
| Housekeeping, Hospital | 1 | 2020 | 4 | 0.170 |
Why?
|
| Employment | 2 | 2019 | 136 | 0.170 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 47 | 0.170 |
Why?
|
| Continuity of Patient Care | 2 | 2012 | 172 | 0.170 |
Why?
|
| Electronic Health Records | 4 | 2024 | 352 | 0.170 |
Why?
|
| Myocardial Infarction | 3 | 2015 | 860 | 0.170 |
Why?
|
| Hospitals | 3 | 2019 | 376 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 3 | 2008 | 153 | 0.170 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 401 | 0.160 |
Why?
|
| Population Surveillance | 2 | 2018 | 205 | 0.160 |
Why?
|
| Disability Evaluation | 1 | 2020 | 216 | 0.160 |
Why?
|
| Algorithms | 3 | 2014 | 992 | 0.160 |
Why?
|
| Interpersonal Relations | 1 | 2020 | 150 | 0.160 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 77 | 0.160 |
Why?
|
| Proteinuria | 1 | 2018 | 37 | 0.150 |
Why?
|
| Length of Stay | 4 | 2020 | 768 | 0.150 |
Why?
|
| Ambulatory Care | 4 | 2015 | 300 | 0.150 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 188 | 0.150 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1022 | 0.150 |
Why?
|
| Buspirone | 1 | 2018 | 3 | 0.150 |
Why?
|
| Amitriptyline | 1 | 2018 | 8 | 0.150 |
Why?
|
| Sotalol | 1 | 2018 | 7 | 0.150 |
Why?
|
| Nurse's Role | 2 | 2011 | 121 | 0.150 |
Why?
|
| Fibric Acids | 1 | 2018 | 2 | 0.150 |
Why?
|
| Nurse Practitioners | 2 | 2011 | 115 | 0.150 |
Why?
|
| Thiazoles | 1 | 2018 | 46 | 0.150 |
Why?
|
| Life Style | 1 | 2020 | 328 | 0.150 |
Why?
|
| Angina, Unstable | 2 | 2015 | 57 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2015 | 63 | 0.150 |
Why?
|
| Cholesterol | 1 | 2019 | 255 | 0.150 |
Why?
|
| Piperazines | 1 | 2018 | 80 | 0.150 |
Why?
|
| Hospital Costs | 1 | 2018 | 120 | 0.140 |
Why?
|
| Polypharmacy | 2 | 2016 | 62 | 0.140 |
Why?
|
| Acute Disease | 2 | 2018 | 658 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2019 | 147 | 0.140 |
Why?
|
| Obesity Management | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cross Infection | 2 | 2017 | 151 | 0.140 |
Why?
|
| Biofouling | 1 | 2017 | 5 | 0.140 |
Why?
|
| Anti-Obesity Agents | 1 | 2017 | 12 | 0.140 |
Why?
|
| Consensus | 1 | 2018 | 193 | 0.140 |
Why?
|
| Methadone | 1 | 2018 | 126 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 74 | 0.140 |
Why?
|
| Buprenorphine | 1 | 2020 | 186 | 0.140 |
Why?
|
| Legionnaires' Disease | 1 | 2017 | 8 | 0.140 |
Why?
|
| Disinfectants | 1 | 2017 | 20 | 0.140 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 87 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2018 | 145 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2017 | 103 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 131 | 0.140 |
Why?
|
| Quality of Health Care | 2 | 2019 | 519 | 0.130 |
Why?
|
| Frail Elderly | 1 | 2017 | 110 | 0.130 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2016 | 6 | 0.130 |
Why?
|
| Texas | 2 | 2017 | 54 | 0.130 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 151 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 387 | 0.130 |
Why?
|
| Copper | 1 | 2017 | 49 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 44 | 0.130 |
Why?
|
| Codeine | 1 | 2016 | 6 | 0.130 |
Why?
|
| Health Policy | 1 | 2018 | 185 | 0.130 |
Why?
|
| Hydrocodone | 1 | 2016 | 6 | 0.130 |
Why?
|
| Inpatients | 4 | 2014 | 295 | 0.130 |
Why?
|
| Spinal Cord Stimulation | 1 | 2016 | 5 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2018 | 159 | 0.130 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2015 | 1 | 0.130 |
Why?
|
| Oxycodone | 1 | 2016 | 32 | 0.130 |
Why?
|
| Air | 1 | 2015 | 16 | 0.130 |
Why?
|
| Endotamponade | 1 | 2015 | 6 | 0.130 |
Why?
|
| Surface-Active Agents | 1 | 2017 | 112 | 0.130 |
Why?
|
| Learning Curve | 1 | 2015 | 23 | 0.130 |
Why?
|
| Headache | 1 | 2016 | 63 | 0.130 |
Why?
|
| Nasal Mucosa | 1 | 2015 | 16 | 0.130 |
Why?
|
| Mood Disorders | 1 | 2016 | 69 | 0.120 |
Why?
|
| Hypolipidemic Agents | 1 | 2015 | 34 | 0.120 |
Why?
|
| Marital Status | 3 | 2020 | 43 | 0.120 |
Why?
|
| Histamine Antagonists | 1 | 2015 | 5 | 0.120 |
Why?
|
| Home Care Services | 2 | 2006 | 101 | 0.120 |
Why?
|
| Pneumococcal Vaccines | 1 | 2015 | 19 | 0.120 |
Why?
|
| Hospital Mortality | 4 | 2007 | 846 | 0.120 |
Why?
|
| Neuromuscular Agents | 1 | 2015 | 18 | 0.120 |
Why?
|
| Spinal Cord | 1 | 2016 | 197 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 705 | 0.120 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 24 | 0.120 |
Why?
|
| Probability | 3 | 2017 | 172 | 0.120 |
Why?
|
| Mass Media | 1 | 2014 | 30 | 0.110 |
Why?
|
| Azithromycin | 1 | 2014 | 26 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2015 | 259 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 114 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2024 | 1306 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2014 | 106 | 0.110 |
Why?
|
| Multiple Trauma | 1 | 2014 | 26 | 0.110 |
Why?
|
| Models, Statistical | 3 | 2012 | 307 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 95 | 0.110 |
Why?
|
| Infant | 3 | 2024 | 1522 | 0.110 |
Why?
|
| Clinical Coding | 1 | 2014 | 43 | 0.110 |
Why?
|
| Long QT Syndrome | 1 | 2013 | 28 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 303 | 0.110 |
Why?
|
| Medication Therapy Management | 1 | 2013 | 25 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 555 | 0.110 |
Why?
|
| Age Distribution | 5 | 2016 | 261 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2015 | 138 | 0.100 |
Why?
|
| Lipids | 1 | 2015 | 307 | 0.100 |
Why?
|
| Psychometrics | 2 | 2019 | 356 | 0.100 |
Why?
|
| Cooperative Behavior | 2 | 2012 | 220 | 0.100 |
Why?
|
| Colony Count, Microbial | 3 | 2018 | 57 | 0.100 |
Why?
|
| Nursing Homes | 1 | 2018 | 665 | 0.100 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2012 | 13 | 0.100 |
Why?
|
| Utilization Review | 1 | 2012 | 31 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 724 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2012 | 34 | 0.100 |
Why?
|
| Body Weight | 2 | 2012 | 380 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1448 | 0.100 |
Why?
|
| Propensity Score | 3 | 2016 | 134 | 0.100 |
Why?
|
| Primary Care Nursing | 1 | 2011 | 3 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 107 | 0.090 |
Why?
|
| Residence Characteristics | 2 | 2018 | 224 | 0.090 |
Why?
|
| Financing, Personal | 1 | 2011 | 25 | 0.090 |
Why?
|
| Long-Term Care | 1 | 2012 | 174 | 0.090 |
Why?
|
| Drug Substitution | 1 | 2011 | 41 | 0.090 |
Why?
|
| Weight Gain | 1 | 2012 | 161 | 0.090 |
Why?
|
| Smoking | 3 | 2007 | 829 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 1029 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 51 | 0.090 |
Why?
|
| Professional-Patient Relations | 2 | 2009 | 128 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2024 | 1838 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2021 | 125 | 0.080 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2021 | 122 | 0.080 |
Why?
|
| Social Stigma | 2 | 2020 | 67 | 0.080 |
Why?
|
| Body Height | 1 | 2010 | 75 | 0.080 |
Why?
|
| Aging | 2 | 2013 | 723 | 0.080 |
Why?
|
| Geriatrics | 1 | 2009 | 41 | 0.080 |
Why?
|
| Telephone | 1 | 2010 | 121 | 0.080 |
Why?
|
| Community Health Services | 1 | 2010 | 128 | 0.080 |
Why?
|
| Midwestern United States | 2 | 2007 | 23 | 0.080 |
Why?
|
| Counseling | 1 | 2011 | 352 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 299 | 0.080 |
Why?
|
| Self Efficacy | 3 | 2007 | 201 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2009 | 250 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2012 | 410 | 0.080 |
Why?
|
| Sleep | 2 | 2022 | 219 | 0.080 |
Why?
|
| Self Disclosure | 1 | 2008 | 37 | 0.070 |
Why?
|
| Sick Role | 1 | 2008 | 15 | 0.070 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 38 | 0.070 |
Why?
|
| HIV Infections | 1 | 2015 | 920 | 0.070 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2007 | 26 | 0.070 |
Why?
|
| Poison Control Centers | 1 | 2007 | 6 | 0.070 |
Why?
|
| Awareness | 1 | 2008 | 74 | 0.070 |
Why?
|
| Regression Analysis | 3 | 2015 | 483 | 0.070 |
Why?
|
| Health Resources | 1 | 2007 | 88 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2007 | 98 | 0.070 |
Why?
|
| Cause of Death | 1 | 2007 | 200 | 0.070 |
Why?
|
| Home Childbirth | 1 | 2006 | 2 | 0.070 |
Why?
|
| Attitude of Health Personnel | 2 | 2011 | 560 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2007 | 59 | 0.070 |
Why?
|
| Social Values | 1 | 2006 | 12 | 0.070 |
Why?
|
| Terminal Care | 1 | 2007 | 95 | 0.070 |
Why?
|
| Attitude to Death | 1 | 2006 | 17 | 0.070 |
Why?
|
| Complementary Therapies | 1 | 2007 | 60 | 0.070 |
Why?
|
| Qualitative Research | 3 | 2021 | 617 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2007 | 576 | 0.060 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 392 | 0.060 |
Why?
|
| Culture | 1 | 2006 | 76 | 0.060 |
Why?
|
| Pneumonia, Bacterial | 1 | 2006 | 86 | 0.060 |
Why?
|
| Radiotherapy Dosage | 1 | 2005 | 79 | 0.060 |
Why?
|
| SEER Program | 1 | 2005 | 65 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2020 | 254 | 0.060 |
Why?
|
| New York City | 1 | 2005 | 75 | 0.060 |
Why?
|
| Intensive Care Units | 3 | 2017 | 449 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 233 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 255 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1055 | 0.060 |
Why?
|
| Outpatients | 1 | 2005 | 132 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 672 | 0.060 |
Why?
|
| Registries | 2 | 2005 | 804 | 0.060 |
Why?
|
| Recurrence | 2 | 2016 | 577 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2005 | 279 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 454 | 0.060 |
Why?
|
| Sepsis | 1 | 2007 | 280 | 0.060 |
Why?
|
| Dibenzothiazepines | 1 | 2003 | 9 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2005 | 268 | 0.060 |
Why?
|
| Risperidone | 1 | 2003 | 25 | 0.050 |
Why?
|
| Clozapine | 1 | 2003 | 30 | 0.050 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2003 | 40 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 566 | 0.050 |
Why?
|
| Estradiol | 1 | 2024 | 242 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2003 | 98 | 0.050 |
Why?
|
| Birth Weight | 1 | 2023 | 84 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 384 | 0.050 |
Why?
|
| Pharmacies | 1 | 2002 | 36 | 0.050 |
Why?
|
| Substance-Related Disorders | 3 | 2015 | 691 | 0.050 |
Why?
|
| Health Behavior | 2 | 2018 | 470 | 0.050 |
Why?
|
| Autistic Disorder | 1 | 2024 | 169 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2005 | 443 | 0.050 |
Why?
|
| Patient Admission | 1 | 2002 | 185 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 1551 | 0.040 |
Why?
|
| Decision Making | 1 | 2004 | 391 | 0.040 |
Why?
|
| Prescriptions | 1 | 2020 | 33 | 0.040 |
Why?
|
| Prazosin | 1 | 2020 | 9 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2002 | 204 | 0.040 |
Why?
|
| Touch | 1 | 2020 | 28 | 0.040 |
Why?
|
| Risk | 2 | 2014 | 373 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2021 | 490 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 254 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2021 | 203 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 670 | 0.040 |
Why?
|
| Physicians | 1 | 2004 | 437 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 96 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2020 | 180 | 0.040 |
Why?
|
| Social Desirability | 1 | 2018 | 5 | 0.040 |
Why?
|
| Thinness | 1 | 2018 | 41 | 0.040 |
Why?
|
| Colorectal Surgery | 1 | 2019 | 52 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 18 | 0.040 |
Why?
|
| Opiate Substitution Treatment | 1 | 2020 | 192 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 95 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 56 | 0.040 |
Why?
|
| Life Change Events | 1 | 2018 | 66 | 0.040 |
Why?
|
| Benchmarking | 1 | 2019 | 135 | 0.040 |
Why?
|
| Respiration, Artificial | 2 | 2011 | 293 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2018 | 160 | 0.040 |
Why?
|
| Minority Groups | 2 | 2009 | 140 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 43 | 0.030 |
Why?
|
| Legionella pneumophila | 1 | 2017 | 10 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 73 | 0.030 |
Why?
|
| Interview, Psychological | 2 | 2009 | 77 | 0.030 |
Why?
|
| Homes for the Aged | 1 | 2018 | 164 | 0.030 |
Why?
|
| Operative Time | 1 | 2016 | 63 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2017 | 92 | 0.030 |
Why?
|
| Failed Back Surgery Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2017 | 176 | 0.030 |
Why?
|
| Overweight | 1 | 2018 | 249 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 286 | 0.030 |
Why?
|
| Educational Status | 2 | 2009 | 271 | 0.030 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2015 | 3 | 0.030 |
Why?
|
| Ocular Hypertension | 1 | 2015 | 7 | 0.030 |
Why?
|
| Phacoemulsification | 1 | 2015 | 6 | 0.030 |
Why?
|
| Trabeculectomy | 1 | 2015 | 9 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 1129 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 214 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2015 | 26 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2015 | 8 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 600 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2015 | 29 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 82 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 279 | 0.030 |
Why?
|
| Drug Labeling | 1 | 2014 | 27 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 200 | 0.030 |
Why?
|
| Citalopram | 1 | 2013 | 17 | 0.030 |
Why?
|
| Cardiology | 1 | 2015 | 163 | 0.030 |
Why?
|
| Data Collection | 2 | 2007 | 384 | 0.030 |
Why?
|
| Medication Systems | 1 | 2012 | 18 | 0.030 |
Why?
|
| Self-Injurious Behavior | 1 | 2012 | 47 | 0.020 |
Why?
|
| National Health Programs | 1 | 2012 | 13 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 2011 | 27 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 306 | 0.020 |
Why?
|
| Airway Management | 1 | 2011 | 55 | 0.020 |
Why?
|
| Focus Groups | 1 | 2011 | 293 | 0.020 |
Why?
|
| Phenytoin | 1 | 2010 | 17 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 64 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2010 | 191 | 0.020 |
Why?
|
| Weight Loss | 1 | 2011 | 260 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2009 | 56 | 0.020 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2009 | 78 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 150 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 214 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 446 | 0.020 |
Why?
|
| Radiography | 1 | 2010 | 510 | 0.020 |
Why?
|
| Hotlines | 1 | 2007 | 22 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 922 | 0.020 |
Why?
|
| Delegation, Professional | 1 | 2007 | 1 | 0.020 |
Why?
|
| Healthy Worker Effect | 1 | 2006 | 4 | 0.020 |
Why?
|
| Professional Autonomy | 1 | 2007 | 21 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 99 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2007 | 52 | 0.020 |
Why?
|
| Physician-Nurse Relations | 1 | 2007 | 26 | 0.020 |
Why?
|
| Hospice Care | 1 | 2007 | 61 | 0.020 |
Why?
|
| Postal Service | 1 | 2006 | 6 | 0.020 |
Why?
|
| Washington | 1 | 2006 | 25 | 0.020 |
Why?
|
| Death Certificates | 1 | 2006 | 9 | 0.020 |
Why?
|
| Geography | 1 | 2006 | 32 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2006 | 27 | 0.020 |
Why?
|
| Bias | 1 | 2006 | 106 | 0.020 |
Why?
|
| Workload | 1 | 2007 | 121 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2005 | 66 | 0.020 |
Why?
|
| Biomarkers | 1 | 2011 | 1198 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 192 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 46 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2006 | 84 | 0.020 |
Why?
|
| Virginia | 1 | 2005 | 16 | 0.020 |
Why?
|
| Palliative Care | 1 | 2007 | 212 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1046 | 0.010 |
Why?
|
| Role | 1 | 2004 | 15 | 0.010 |
Why?
|
| Psychology | 1 | 2004 | 47 | 0.010 |
Why?
|
| Health Personnel | 1 | 2008 | 343 | 0.010 |
Why?
|
| Mastectomy | 1 | 2004 | 52 | 0.010 |
Why?
|
| Mastectomy, Segmental | 1 | 2004 | 45 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 279 | 0.010 |
Why?
|
| Physician's Role | 1 | 2004 | 120 | 0.010 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2002 | 9 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 736 | 0.010 |
Why?
|
| Stroke | 1 | 2011 | 1138 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2007 | 679 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 221 | 0.010 |
Why?
|
| Communication | 1 | 2004 | 555 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 19646 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 1244 | 0.010 |
Why?
|